Europe Pompe Disease Drugs Market Research Report Forecast 2017 to 2022

December 2017 | 126 pages | ID: E37068670DEEN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The Europe Pompe Disease Drugs Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Pompe Disease Drugs industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Pompe Disease Drugs market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Europe Pompe Disease Drugs Market Analysis by Countries:
Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:
Genzyme（A Sanofi Company)
BioMarin
Amicus
Audentes
EpiVax
Oxyrane
Sangamo
Valerion Therapeutics
company 9

Europe Pompe Disease Drugs Market Analysis by Product:
Liver Drugs
Heart Drugs
Muscle Drugs

Europe Pompe Disease Drugs Market Analysis by Application:
Hospital
Clinic
Other

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

1 POMPE DISEASE DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Pompe Disease Drugs
1.2 Classification of Pompe Disease Drugs
  1.2.1 Liver Drugs
  1.2.2 Heart Drugs
  1.2.3 Muscle Drugs
1.3 Application of Pompe Disease Drugs
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Other
1.4 Pompe Disease Drugs Market States Status and Prospect (2012-2022) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Pompe Disease Drugs (2012-2022)
  1.5.1 Europe Pompe Disease Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Europe Pompe Disease Drugs Revenue and Growth Rate (2012-2022)

2 EUROPE ECONOMIC IMPACT ON POMPE DISEASE DRUGS INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 POMPE DISEASE DRUGS MANUFACTURING COST ANALYSIS

3.1 Pompe Disease Drugs Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Pompe Disease Drugs

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Pompe Disease Drugs Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Pompe Disease Drugs Major Manufacturers in 2016
4.4 Downstream Buyers

5 EUROPE POMPE DISEASE DRUGS MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Pompe Disease Drugs Market Competition by Manufacturers
  5.1.1 Europe Pompe Disease Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Pompe Disease Drugs Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Pompe Disease Drugs (Volume and Value) by Type
  5.2.1 Europe Pompe Disease Drugs Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Pompe Disease Drugs Revenue and Market Share by Type (2012-2017)
5.3 Europe Pompe Disease Drugs (Volume and Value) by Countries
  5.3.1 Europe Pompe Disease Drugs Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Pompe Disease Drugs Revenue and Market Share by Countries (2012-2017)
5.4 Europe Pompe Disease Drugs (Volume) by Application

6 GERMANY POMPE DISEASE DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Pompe Disease Drugs Sales and Value (2012-2017)
  6.1.1 Germany Pompe Disease Drugs Sales and Growth Rate (2012-2017)
  6.1.2 Germany Pompe Disease Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Pompe Disease Drugs Sales Price Trend (2012-2017)
6.2 Germany Pompe Disease Drugs Sales and Market Share by Manufacturers
6.3 Germany Pompe Disease Drugs Sales and Market Share by Type
6.4 Germany Pompe Disease Drugs Sales and Market Share by Application

7 FRANCE POMPE DISEASE DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 France Pompe Disease Drugs Sales and Value (2012-2017)
  7.1.1 France Pompe Disease Drugs Sales and Growth Rate (2012-2017)
  7.1.2 France Pompe Disease Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 France Pompe Disease Drugs Sales Price Trend (2012-2017)
7.2 France Pompe Disease Drugs Sales and Market Share by Manufacturers
7.3 France Pompe Disease Drugs Sales and Market Share by Type
7.4 France Pompe Disease Drugs Sales and Market Share by Application

8 UK POMPE DISEASE DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 UK Pompe Disease Drugs Sales and Value (2012-2017)
  8.1.1 UK Pompe Disease Drugs Sales and Growth Rate (2012-2017)
  8.1.2 UK Pompe Disease Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 UK Pompe Disease Drugs Sales Price Trend (2012-2017)
8.2 UK Pompe Disease Drugs Sales and Market Share by Manufacturers
8.3 UK Pompe Disease Drugs Sales and Market Share by Type
8.4 UK Pompe Disease Drugs Sales and Market Share by Application

9 RUSSIA POMPE DISEASE DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Pompe Disease Drugs Sales and Value (2012-2017)
  9.1.1 Russia Pompe Disease Drugs Sales and Growth Rate (2012-2017)
  9.1.2 Russia Pompe Disease Drugs Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Pompe Disease Drugs Sales Price Trend (2012-2017)
9.2 Russia Pompe Disease Drugs Sales and Market Share by Manufacturers
9.3 Russia Pompe Disease Drugs Sales and Market Share by Type
9.4 Russia Pompe Disease Drugs Sales and Market Share by Application

10 ITALY POMPE DISEASE DRUGS (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Pompe Disease Drugs Sales and Value (2012-2017)
  10.1.1 Italy Pompe Disease Drugs Sales and Growth Rate (2012-2017)
  10.1.2 Italy Pompe Disease Drugs Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Pompe Disease Drugs Sales Price Trend (2012-2017)
10.2 Italy Pompe Disease Drugs Sales and Market Share by Manufacturers
10.3 Italy Pompe Disease Drugs Sales and Market Share by Type
10.4 Italy Pompe Disease Drugs Sales and Market Share by Application

11 SPAIN POMPE DISEASE DRUGS (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Pompe Disease Drugs Sales and Value (2012-2017)
  11.1.1 Spain Pompe Disease Drugs Sales and Growth Rate (2012-2017)
  11.1.2 Spain Pompe Disease Drugs Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Pompe Disease Drugs Sales Price Trend (2012-2017)
11.2 Spain Pompe Disease Drugs Sales and Market Share by Manufacturers
11.3 Spain Pompe Disease Drugs Sales and Market Share by Type
11.4 Spain Pompe Disease Drugs Sales and Market Share by Application

12 BENELUX POMPE DISEASE DRUGS (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Pompe Disease Drugs Sales and Value (2012-2017)
  12.1.1 Benelux Pompe Disease Drugs Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Pompe Disease Drugs Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Pompe Disease Drugs Sales Price Trend (2012-2017)
12.2 Benelux Pompe Disease Drugs Sales and Market Share by Manufacturers
12.3 Benelux Pompe Disease Drugs Sales and Market Share by Type
12.4 Benelux Pompe Disease Drugs Sales and Market Share by Application

13 EUROPE POMPE DISEASE DRUGS MANUFACTURERS ANALYSIS

13.1 Genzyme（A Sanofi Company)
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 BioMarin
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 Amicus
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 Audentes
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 EpiVax
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 Oxyrane
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Sangamo
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 Valerion Therapeutics
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 company
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE POMPE DISEASE DRUGS MARKET FORECAST (2017-2022)

15.1 Germany Market Forecast (2017-2022)
15.2 France Market Forecast (2017-2022)
15.3 UK Market Forecast (2017-2022)
15.4 Russia Market Forecast (2017-2022)
15.5 Italy Market Forecast (2017-2022)
15.6 Spain Market Forecast (2017-2022)
15.7 Benelux Market Forecast (2017-2022)
15.8 Europe Pompe Disease Drugs Market Forecast by Type (2017-2022)
15.9 Europe Pompe Disease Drugs Market Forecast by Application (2017-2022)

16 APPENDIX

List Of Tables

LIST OF TABLES

Figure Picture of Pompe Disease Drugs
Table Classification of Pompe Disease Drugs
Figure Europe Sales Market Share of Pompe Disease Drugs by Type in 2016
Table Application of Pompe Disease Drugs
Figure Europe Sales Market Share of Pompe Disease Drugs by Application in 2016
Figure Germany Pompe Disease Drugs Revenue and Growth Rate (2012-2022)
Figure France Pompe Disease Drugs Revenue and Growth Rate (2012-2022)
Figure UK Pompe Disease Drugs Revenue and Growth Rate (2012-2022)
Figure Russia Pompe Disease Drugs Revenue and Growth Rate (2012-2022)
Figure Italy Pompe Disease Drugs Revenue and Growth Rate (2012-2022)
Figure Spain Pompe Disease Drugs Revenue and Growth Rate (2012-2022)
Figure Benelux Pompe Disease Drugs Revenue and Growth Rate (2012-2022)
Figure Europe Pompe Disease Drugs Sales and Growth Rate (2012-2022)
Figure Europe Pompe Disease Drugs Revenue and Growth Rate (2012-2022)
Table Europe Pompe Disease Drugs Sales of Key Manufacturers (2015 and 2016)
Table Europe Pompe Disease Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Pompe Disease Drugs Sales Share by Manufacturers
Figure 2016 Pompe Disease Drugs Sales Share by Manufacturers
Table Europe Pompe Disease Drugs Revenue by Manufacturers (2015 and 2016)
Table Europe Pompe Disease Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Pompe Disease Drugs Revenue Share by Manufacturers
Table 2016 Europe Pompe Disease Drugs Revenue Share by Manufacturers
Table Europe Pompe Disease Drugs Sales and Market Share by Type (2012-2017)
Table Europe Pompe Disease Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Pompe Disease Drugs by Type (2012-2017)
Figure Europe Pompe Disease Drugs Sales Growth Rate by Type (2012-2017)
Table Europe Pompe Disease Drugs Revenue and Market Share by Type (2012-2017)
Table Europe Pompe Disease Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Pompe Disease Drugs by Type (2012-2017)
Figure Europe Pompe Disease Drugs Revenue Growth Rate by Type (2012-2017)
Table Europe Pompe Disease Drugs Sales and Market Share by Countries (2012-2017)
Table Europe Pompe Disease Drugs Sales Share by Countries (2012-2017)
Figure Sales Market Share of Pompe Disease Drugs by Countries (2012-2017)
Table Europe Pompe Disease Drugs Revenue and Market Share by Countries (2012-2017)
Table Europe Pompe Disease Drugs Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Pompe Disease Drugs by Countries (2012-2017)
Table Europe Pompe Disease Drugs Sales and Market Share by Application (2012-2017)
Table Europe Pompe Disease Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Pompe Disease Drugs by Application (2012-2017)
Figure Germany Pompe Disease Drugs Sales and Growth Rate (2012-2017)
Figure Germany Pompe Disease Drugs Revenue and Growth Rate (2012-2017)
Figure Germany Pompe Disease Drugs Sales Price Trend (2012-2017)
Table Germany Pompe Disease Drugs Sales by Manufacturers (2015 and 2016)
Table Germany Pompe Disease Drugs Market Share by Manufacturers (2015 and 2016)
Table Germany Pompe Disease Drugs Sales by Type (2015 and 2016)
Table Germany Pompe Disease Drugs Market Share by Type (2015 and 2016)
Table Germany Pompe Disease Drugs Sales by Application (2015 and 2016)
Table Germany Pompe Disease Drugs Market Share by Application (2015 and 2016)
Figure France Pompe Disease Drugs Sales and Growth Rate (2012-2017)
Figure France Pompe Disease Drugs Revenue and Growth Rate (2012-2017)
Figure France Pompe Disease Drugs Sales Price Trend (2012-2017)
Table France Pompe Disease Drugs Sales by Manufacturers (2015 and 2016)
Table France Pompe Disease Drugs Market Share by Manufacturers (2015 and 2016)
Table France Pompe Disease Drugs Sales by Type (2015 and 2016)
Table France Pompe Disease Drugs Market Share by Type (2015 and 2016)
Table France Pompe Disease Drugs Sales by Application (2015 and 2016)
Table France Pompe Disease Drugs Market Share by Application (2015 and 2016)
Figure UK Pompe Disease Drugs Sales and Growth Rate (2012-2017)
Figure UK Pompe Disease Drugs Revenue and Growth Rate (2012-2017)
Figure UK Pompe Disease Drugs Sales Price Trend (2012-2017)
Table UK Pompe Disease Drugs Sales by Manufacturers (2015 and 2016)
Table UK Pompe Disease Drugs Market Share by Manufacturers (2015 and 2016)
Table UK Pompe Disease Drugs Sales by Type (2015 and 2016)
Table UK Pompe Disease Drugs Market Share by Type (2015 and 2016)
Table UK Pompe Disease Drugs Sales by Application (2015 and 2016)
Table UK Pompe Disease Drugs Market Share by Application (2015 and 2016)
Figure Russia Pompe Disease Drugs Sales and Growth Rate (2012-2017)
Figure Russia Pompe Disease Drugs Revenue and Growth Rate (2012-2017)
Figure Russia Pompe Disease Drugs Sales Price Trend (2012-2017)
Table Russia Pompe Disease Drugs Sales by Manufacturers (2015 and 2016)
Table Russia Pompe Disease Drugs Market Share by Manufacturers (2015 and 2016)
Table Russia Pompe Disease Drugs Sales by Type (2015 and 2016)
Table Russia Pompe Disease Drugs Market Share by Type (2015 and 2016)
Table Russia Pompe Disease Drugs Sales by Application (2015 and 2016)
Table Russia Pompe Disease Drugs Market Share by Application (2015 and 2016)
Figure Italy Pompe Disease Drugs Sales and Growth Rate (2012-2017)
Figure Italy Pompe Disease Drugs Revenue and Growth Rate (2012-2017)
Figure Italy Pompe Disease Drugs Sales Price Trend (2012-2017)
Table Italy Pompe Disease Drugs Sales by Manufacturers (2015 and 2016)
Table Italy Pompe Disease Drugs Market Share by Manufacturers (2015 and 2016)
Table Italy Pompe Disease Drugs Sales by Type (2015 and 2016)
Table Italy Pompe Disease Drugs Market Share by Type (2015 and 2016)
Table Italy Pompe Disease Drugs Sales by Application (2015 and 2016)
Table Italy Pompe Disease Drugs Market Share by Application (2015 and 2016)
Figure Spain Pompe Disease Drugs Sales and Growth Rate (2012-2017)
Figure Spain Pompe Disease Drugs Revenue and Growth Rate (2012-2017)
Figure Spain Pompe Disease Drugs Sales Price Trend (2012-2017)
Table Spain Pompe Disease Drugs Sales by Manufacturers (2015 and 2016)
Table Spain Pompe Disease Drugs Market Share by Manufacturers (2015 and 2016)
Table Spain Pompe Disease Drugs Sales by Type (2015 and 2016)
Table Spain Pompe Disease Drugs Market Share by Type (2015 and 2016)
Table Spain Pompe Disease Drugs Sales by Application (2015 and 2016)
Table Spain Pompe Disease Drugs Market Share by Application (2015 and 2016)
Figure Benelux Pompe Disease Drugs Sales and Growth Rate (2012-2017)
Figure Benelux Pompe Disease Drugs Revenue and Growth Rate (2012-2017)
Figure Benelux Pompe Disease Drugs Sales Price Trend (2012-2017)
Table Benelux Pompe Disease Drugs Sales by Manufacturers (2015 and 2016)
Table Benelux Pompe Disease Drugs Market Share by Manufacturers (2015 and 2016)
Table Benelux Pompe Disease Drugs Sales by Type (2015 and 2016)
Table Benelux Pompe Disease Drugs Market Share by Type (2015 and 2016)
Table Benelux Pompe Disease Drugs Sales by Application (2015 and 2016)
Table Benelux Pompe Disease Drugs Market Share by Application (2015 and 2016)
Table Genzyme（A Sanofi Company) Basic Information List
Table Genzyme（A Sanofi Company) Pompe Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Genzyme（A Sanofi Company) Pompe Disease Drugs Sales Market Share (2012-2017)
Table BioMarin Basic Information List
Table BioMarin Pompe Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table BioMarin Pompe Disease Drugs Sales Market Share (2012-2017)
Table Amicus Basic Information List
Table Amicus Pompe Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Amicus Pompe Disease Drugs Sales Market Share (2012-2017)
Table Audentes Basic Information List
Table Audentes Pompe Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Audentes Pompe Disease Drugs Sales Market Share (2012-2017)
Table EpiVax Basic Information List
Table EpiVax Pompe Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure EpiVax Pompe Disease Drugs Sales Market Share (2012-2017)
Table Oxyrane Basic Information List
Table Oxyrane Pompe Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Oxyrane Pompe Disease Drugs Sales Market Share (2012-2017)
Table Sangamo Basic Information List
Table Sangamo Pompe Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sangamo Pompe Disease Drugs Sales Market Share (2012-2017)
Table Valerion Therapeutics Basic Information List
Table Valerion Therapeutics Pompe Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Valerion Therapeutics Pompe Disease Drugs Sales Market Share (2012-2017)
Table company 9 Basic Information List
Table company 9 Pompe Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure company 9 Pompe Disease Drugs Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pompe Disease Drugs
Figure Manufacturing Process Analysis of Pompe Disease Drugs
Figure Pompe Disease Drugs Industrial Chain Analysis
Table Raw Materials Sources of Pompe Disease Drugs Major Manufacturers in 2016
Table Major Buyers of Pompe Disease Drugs
Table Distributors/Traders List
Figure Germany Pompe Disease Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Germany Pompe Disease Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure France Pompe Disease Drugs Sales and Growth Rate Forecast (2017-2022)
Figure France Pompe Disease Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure UK Pompe Disease Drugs Sales and Growth Rate Forecast (2017-2022)
Figure UK Pompe Disease Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Pompe Disease Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Russia Pompe Disease Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Pompe Disease Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Italy Pompe Disease Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Pompe Disease Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Spain Pompe Disease Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Pompe Disease Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Pompe Disease Drugs Revenue and Growth Rate Forecast (2017-2022)
Table Europe Pompe Disease Drugs Sales Forecast by Type (2017-2022)
Table Europe Pompe Disease Drugs Sales Forecast by Application (2017-2022)

COMPANIES MENTIONED

Genzyme（A Sanofi Company)
BioMarin
Amicus
Audentes
EpiVax
Oxyrane
Sangamo
Valerion Therapeutics